Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.

Rheumatology (Oxford, England)

Volumn 50, Issue 11, 2011, Pages 1955-1968

  Hazes, Johanna M W ^a   Coulie, Pierre G ^b   Geenen, Vincent ^b   Vermeire, Séverine ^b   Carbonnel, Franck ^b   Louis, Edouard ^b   Masson, Pierre ^b   De Keyser, Filip ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CONGENITAL MALFORMATION; DRUG ANTAGONISM; ENVIRONMENTAL EXPOSURE; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RHEUMATOID ARTHRITIS;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84555177996     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker302     Document Type: Review

References (0)